Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains

Vaccine

Volumn 24, Issue 14, 2006, Pages 2662-2668

  Rubin, Steven ^a,b   Mauldin, Jeremy ^a   Chumakov, Konstantin ^a   Vanderzanden, Jackie ^a   Iskow, Rebecca ^a   Carbone, Kathryn ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Antibody; Efficacy; Mumps virus; Neutralization; Protection; Vaccine

Indexed keywords

HN PROTEIN; LIVE VACCINE; MUMPS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; IMMUNE RESPONSE; MUMPS VIRUS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEROLOGY; SEROTYPE; SERUM; STRAIN DIFFERENCE; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MUMPS VACCINE; MUMPS VIRUS; NEUTRALIZATION TESTS; PHYLOGENY;

EID: 33344469057     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.10.050     Document Type: Article

References (49)

1. Centers for Disease Control and Prevention, Mumps - United States, 1984-1985, MMWR 1986;35:216-9.
2. P.P. Mortimore Mumps prophylaxis in the light of a new test for antibody Br Med J 2 1978 1523 1524
3. P.A. Briss, L.J. Fehrs, R.A. Parker, P.F. Wright, E.C. Sannella, and R.H. Hutcheson Sustained transmission of mumps in a highly vaccinated population-assessment of primary vaccine failure and waning vaccine-induced immunity J Infect Dis 169 1994 77 82
4. B.S. Hersh, P.E. Fine, W.K. Kent, S.L. Cochi, L.H. Kahn, and E.R. Zell Mumps outbreak in a highly vaccinated population J Pediatr 119 1991 187 193
5. J.L. Richard, M. Zwahlen, M. Feuz, and H.C. Matter Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: a case-cohort study Eur J Epidemiol 18 6 2003 569 577
6. G. Goncalves, A. De Araujo, and M.L. Monteiro Cardoso Outbreak of mumps associated with poor vaccine efficacy - Oporto, Portugal, 1996 Euro Surveill 3 12 1998 119 121
7. J.E. Cheek, R. Baron, H. Atlas, D.L. Wilson, and R.D. Crider Mumps outbreak in a highly vaccinated school population Arch Pediatr Adolesc Med 149 1995 774 778
8. J.P. Gut, C. Lablache, S. Behr, and A. Kirn Symptomatic mumps virus reinfections J Med Virol 45 1 1995 17 23
9. B. Crowley, and M.A. Afzal Mumps virus reinfection - clinical findings and serological vagaries Commun Dis Public Health 5 4 2002 311 313
10. J. Nojd, T. Tecle, A. Samuelsson, and C. Orvell Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype Vaccine 19 13-14 2001 1727 1731
11. J. Kövamees, R. Rydbeck, C. Örvell, and E. Norrby Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham virus Virus Res 17 1990 119 130
12. C. Orvell, A.R. Alsheikhly, M. Kalantari, and B. Johansson Characterization of genotype-specific epitopes of the HN protein of mumps virus J Gen Virol 78 Part 12 1997 3187 3193
13. M.G. Cusi, S. Fischer, R. Sedlmeier, M. Valassina, P.E. Valensin, and M. Donati Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein Virus Res 74 1-2 2001 133 137
14. C. Orvell, T. Tecle, B. Johansson, H. Saito, and A. Samuelson Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus J Gen Virol 83 Part 10 2002 2489 2496
15. T. Tecle, B. Johansson, A. Jejcic, M. Forsgren, and C. Orvell Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus J Gen Virol 79 Part 12 1998 2929 2937
16. M. Montes, G. Cilla, J. Artieda, D. Vicente, and M. Basterretxea Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain Epidemiol Infect 129 3 2002 551 556
17. P.J. Yates, M.A. Afzal, and P.D. Minor Antigenic and genetic variation of the HN protein of mumps virus strains J Gen Virol 77 Part 10 1996 2491 2497
18. C. Orvell Immunological properties of purified mumps virus glycoproteins J Gen Virol 41 3 1978 517 526
19. C. Orvell The reactions of monoclonal antibodies with structural proteins of mumps virus J Immunol 132 5 1984 2622 2629
20. A.C. Server, D.C. Merz, M.N. Waxham, and J.S. Wolinsky Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein Infect Immun 35 1982 179 186
21. K.M. Chumakov, and S.V. Iushmanov A principle of maximum topological similarity in molecular systematics Mol Gen Mikrobiol Virusol 3 1988 3 9
22. S.V. Iushmanov, and K.M. Chumakov Algorithms for constructing phylogenetic trees of maximum topological similarity Mol Gen Mikrobiol Virusol 3 1988 9 15
23. S.A. Rubin, M. Pletnikov, and K.M. Carbone Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain J Virol 72 10 1998 8037 8042
24. C.S. Lim, K.P. Chan, K.T. Goh, and V.T. Chow Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore J Med Virol 70 2 2003 287 292
25. R.P. Yeo, M.A. Afzal, T. Forsey, and B.K. Rima Identification of a new mumps virus lineage by nucleotide sequence analysis of the SH gene of ten different strains Arch Virol 128 1993 371 377
26. T. Tecle, B. Bottiger, C. Orvell, and B. Johansson Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype J Gen Virol 82 Part 11 2001 2675 2680
27. K. Uchida, M. Shinohara, S. Shimada, Y. Segawa, K. Kimura, and Y. Hoshino Characterization of the F gene of contemporary mumps virus strains isolated in Japan Microbiol Immunol 47 2 2003 167 172
28. T. Tecle, A. Mickiene, B. Johansson, L. Lindquist, and C. Orvell Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2002 Arch Virol 147 2 2002 243 253
29. Y. Inou, T. Nakayama, N. Yoshida, H. Uejima, K. Yuri, and M. Kamada Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes J Med Virol 73 1 2004 97 104
30. L. Jin, B. Rima, D. Brown, C. Orvell, T. Tecle, and M. Afzal Proposal for genetic characterisation of wild-type mumps strains: Preliminary standardisation of the nomenclature Arch Virol 2005
31. B. Johansson, T. Tecle, and C. Orvell Proposed criteria for classification of new genotypes of mumps virus Scand J Infect Dis 34 5 2002 355 357
32. K. Takeuchi, K. Tanabayashi, M. Hishiyama, and A. Yamada The mumps virus SH protein is a membrane protein and not essential for virus growth Virology 225 1 1996 156 162
33. S.A. Tsarev, M.L. Sanders, D.W. Vaughn, and B.L. Innis Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus Vaccine 18 Suppl. 2 2000 36 43
34. P.A. Pipkin, M.A. Afzal, A.B. Heath, and P.D. Minor Assay of humoral immunity to mumps virus J Virol Methods 79 1999 219 225
35. F.A. Ennis Immunity to mumps in an institutional epidemic. Correlation of insusceptibility to mumps with serum plaque neutralizing and hemagglutination-inhibiting antibodies J Infect Dis 119 6 1969 654 657
36. C.W. Biedel Recurrent mumps parotitis following natural infection and immunization Am J Dis Child 132 7 1978 678 680
37. R.E. Weibel, E.B. Buynak, A.A. McLean, and M.R. Hilleman Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines Pediatrics 61 1 1978 5 11
38. R.E. Weibel, E.B. Buynak, J. Stokes Jr., and M.R. Hilleman Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine Pediatrics 45 5 1970 821 826
39. R.E. Weibel, E.B. Buynak, J.E. Whitman Jr., M.B. Leagus, J. Stokes Jr., and M.R. Hilleman Jeryl Lynn strain live mumps virus vaccine Durable immunity for three years following vaccination JAMA 207 9 1969 1667 1670
40. M.R. Hilleman, R.E. Weibel, E.B. Buynak, J. Stokes Jr., and J.E. Whitman Jr. Live attenuated mumps-virus vaccine IV. Protective efficacy as measured in a field evaluation N Engl J Med 276 5 1967 252 258
41. R.E. Weibel, J. Stokes Jr., E.B. Buynak, J.E. Whitman Jr., and M.R. Hilleman Live attenuated mumps-virus vaccine 3. Clinical and serologic aspects in a field evaluation N Engl J Med 276 5 1967 245 251
42. C. Vandermeulen, M. Roelants, M. Vermoere, K. Roseeuw, P. Goubau, and K. Hoppenbrouwers Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 22 21-22 2004 2713 2716
43. E. Savage, M. Ramsay, J. White, S. Beard, H. Lawson, and R. Hunjan Mumps outbreaks across England and Wales in 2004: observational study BMJ 330 7500 2005 1119 1120
44. M. Wharton, S.L. Cochi, R.H. Hutcheson, J.M. Bistowish, and W. Schaffner A large outbreak of mumps in the postvaccine era J Infect Dis 158 1988 1253 1260
45. D. Germann, A. Ströhle, K. Eggenberger, C.E. Steiner, and L. Matter An outbreak of mumps in a population partially vaccinated with the Rubini strain Scand J Infect Dis 28 1996 235 238
46. R.C. Cruz, I.M. Rodriguez, J. Olvera, and G.M. Alvarez Study of the immune response engendered by differents combined measles, mumps and rubella (MMR) vaccines in an area of Andalusia (Spain) Vaccine 22 2 2003 280 286
47. A. Tischer, and E. Gerike Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella Vaccine 18 14 2000 1382 1392
48. M. Schlegel, and P.L. Vernazza Immune response and vaccine efficiency Vaccine 16 13 1998 1256
49. S. Utz, J.L. Richard, S. Capaul, H.C. Matter, M.G. Hrisoho, and K. Muhlemann Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland, 1998-2000 J Med Virol 73 1 2004 91 96